beta-D-Galactose pentaacetate CAS 4163-60-4
Assay:98% min
Appearance:White crystalline powder
Packaging:25kg /drum
Sample: available
related documents:
COA of beta-D-Galactose pentaacetate
TDS of beta-D-Galactose pentaacetate
MSDS of beta-D-Galactose pentaacetate
Request for product documents
Beta-D-Galactose Pentaacetate (CAS 4163-60-4) Ultimate User Guide
Table of Contents
- 1. Product Specifications & Comparative Analysis
- 2. Comprehensive Applications
- 3. Practical Usage Scenarios
- 4. Verified Customer Case Studies
- 5. Professional Inquiry Guidance
1. Product Specifications & Comparative Analysis
| Parameter | Beta-D-Galactose Pentaacetate | Beta-D-Glucose Pentaacetate |
|---|---|---|
| CAS Number | 4163-60-4 | 604-68-2 |
| Molecular Formula | C16H22O11 | C16H22O11 |
| Molecular Weight | 390.34 g/mol | 390.34 g/mol |
| Appearance | White crystalline powder | White crystalline solid |
| Purity | ≥98% (HPLC) | ≥97% |
| Solubility | Chloroform, DMSO | Acetone, Ethanol |
| Storage Conditions | 2-8°C in sealed container | Room temperature |
2. Comprehensive Applications
2.1 Organic Synthesis Intermediate
Essential for preparing galactose derivatives through selective deacetylation reactions. Critical in carbohydrate chemistry for synthesizing:
– Glycosyl donors
– Oligosaccharide building blocks
– Protected sugar intermediates
2.2 Pharmaceutical Applications
Key raw material for:
– Antidiabetic drug development
– Lactose intolerance treatment research
– Glycoprotein synthesis
– Vaccine adjuvant production
2.3 Biochemical Research
– Substrate for galactosidase enzymes
– Carbohydrate metabolism studies
– Glycosylation pattern analysis
3. Practical Usage Scenarios
3.1 Pharmaceutical Synthesis
Used in multi-step synthesis of Miglitol (anti-diabetic drug):
Reaction Scheme:
C16H22O11 → [Deacetylation] → C6H12O6 → [Amination] → Active pharmaceutical ingredient
3.2 Oligosaccharide Preparation
Step-by-step process:
1. Dissolve in anhydrous DCM (10% w/v)
2. Add BF3·Et2O catalyst (0.5 eq)
3. React with appropriate glycosyl acceptor
4. Purify via column chromatography
4. Verified Customer Case Studies
4.1 PharmaSynth Co., Ltd. (Germany)
Challenge: Needed high-purity galactose derivatives for GMP-compliant drug production
Solution: Customized batch production with:
– 99.2% HPLC purity
– Residual solvent <50ppm
Result: 30% yield improvement in API synthesis
4.2 BioCarb Solutions (USA)
Research Objective: Develop novel galactosidase inhibitors
Application: Used as primary substrate in:
– Enzyme kinetics studies (Km = 2.4 mM)
– High-throughput screening assays
Outcome: Identified 3 lead compounds with IC50 < 10μM
5. Professional Inquiry Guidance
Why Choose Us?
– ISO 9001 Certified Production
– Batch-to-Batch Consistency Guarantee
– Custom Synthesis Available
– Global Logistics Support
Contact Technical Experts:
Email: info@vivalr.com
Tel: (86) 15866781826
Office Hours: Mon-Fri 08:30-17:30 GMT+8
Request Quotation:
Include:
1. Required quantity (gram to kilogram scale)
2. Purity specifications
3. Preferred packaging
4. Destination country



评论
目前还没有评论。